qPCR (Figure 6E) and Western blot (Figure 6F) assays showed that FOXM1 and its downstream targets cyclin B1 and cyclin D1 were notably downregulated in LOC653786-silencing RCC xenografts. The gene discussed is FOXM1; the disease is renal cell carcinoma.